RD7.6 | Breast Cancer Screening and Imaging in Management — Summary & Reflection

KEY TAKEAWAYS

Breast Cancer Screening and Imaging in Management — Key Points

• Two scenarios: asymptomatic screening (mammography) and symptomatic assessment of a lump (triple assessment: clinical examination + imaging + pathology).
• Mammography is the SCREENING modality — low-dose X-ray detecting small impalpable cancers and microcalcifications; sensitivity falls in dense (younger) breasts. Screening age ranges are programme-dependent (commonly ~50-69; from ~40 in some).
• Ultrasound is the adjunct and first-line in specific groups — characterises masses (solid vs cystic), modality of choice in young women (<~40), dense breasts, and pregnancy/lactation (no ionising radiation); guides biopsy and assesses axillary nodes.
• MRI is high-sensitivity, targeted use — high-risk screening (BRCA carriers, strong family history), staging/extent, equivocal cases, implant assessment; uses gadolinium, not ionising radiation; lower specificity.
• BI-RADS categories 0-6 carry management actions: 0 incomplete (more imaging); 1 negative / 2 benign (routine/reassure); 3 probably benign (short-interval follow-up); 4 suspicious / 5 highly suggestive (image-guided core biopsy); 6 known malignancy.
• Triple-assessment concordance is mandatory — a benign mammogram does NOT exclude cancer in a clinically suspicious lump; discordance is investigated further, never dismissed.
• Staging uses CT/bone scan/PET-CT for distant metastases (not for the primary); mammography/USG/MRI define local-regional extent and axillary nodal status; MRI assesses neoadjuvant response. Imaging informs a multidisciplinary plan.

REFLECT

When you next see a woman referred with a breast concern, notice how the team chooses the imaging: do they distinguish the asymptomatic screening attendee from the symptomatic lump, and does the modality fit the woman's age and breast density? Watch how the BI-RADS category on the report is used — is it translated into a clear action, or merely filed? Pay attention to whether triple-assessment concordance is checked, and what happens when a clinically suspicious lump meets a benign-looking image. Building the habit of matching modality to indication, reading BI-RADS as an instruction, and respecting discordance is what turns a breast imaging report into safe, timely care for women at risk of the commonest cancer they face.